ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,119Medicare Part D Prescriptions Filled, Including Refills

Rank: 1193 out of 3647

$453K Total Retail Price of All Prescriptions

Rank: 1289 out of 3647

539 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 539 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 539 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 334 262 1 4
SIMVASTATIN 290 249 2 1
METOPROLOL TARTRATE 280 240 3 7
LEVOTHYROXINE SODIUM 273 234 4 5
HYDROCODONE-ACETAMINOPHEN 271 243 S3 5 12
FUROSEMIDE 238 216 6 8
WARFARIN SODIUM 233 209 7 15
OMEPRAZOLE 224 178 8 3
AMLODIPINE BESYLATE 159 152 9 2
POTASSIUM CHLORIDE 158 152 10 24
TRAMADOL HCL 127 106 11 22
MIRTAZAPINE 115 115 12 63
GABAPENTIN 113 102 13 17
NAMENDA 105 105 14 49
DONEPEZIL HCL 102 102 15 30
PLAVIX 96 90 16 39
CLOPIDOGREL 94 74 17 26
LEVEMIR 89 86 18 187
CARVEDILOL 88 74 19 20
ISOSORBIDE MONONITRATE ER 87 87 20 56
CYMBALTA 84 81 21 79
HYDROCHLOROTHIAZIDE 78 63 22 9
POLYETHYLENE GLYCOL 3350 75 67 23 143
ESCITALOPRAM OXALATE 71 61 24 65
ZOLPIDEM TARTRATE 69 62 25 14
NOVOLOG 68 65 26 123
METOPROLOL SUCCINATE 68 67 26 18
CIPROFLOXACIN HCL 67 52 28 53
DIOVAN 66 66 29 40
FLUOXETINE HCL 63 39 30 68
RAMIPRIL 61 49 31 101
LEVETIRACETAM 57 55 32 122
NEXIUM 54 20 33 44
CITALOPRAM HBR 54 45 33 25
SPIRONOLACTONE 53 38 35 77
PREDNISONE 52 46 36 43
DIGOXIN 52 50 36 51
ATENOLOL 51 49 38 10
TAMSULOSIN HCL 51 50 38 28
FAMOTIDINE 50 48 40 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.